| A proteome-scale map of the human interactome network T Rolland, M Taşan, B Charloteaux, SJ Pevzner, Q Zhong, N Sahni, S Yi, ... Cell 159 (5), 1212-1226, 2014 | 1025 | 2014 |
| Uncovering disease-disease relationships through the incomplete interactome J Menche, A Sharma, M Kitsak, SD Ghiassian, M Vidal, J Loscalzo, ... Science 347 (6224), 2015 | 876 | 2015 |
| A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome SD Ghiassian, J Menche, AL Barabási PLoS Comput Biol 11 (4), e1004120, 2015 | 222 | 2015 |
| A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma A Sharma, J Menche, CC Huang, T Ort, X Zhou, M Kitsak, N Sahni, ... Human molecular genetics 24 (11), 3005-3020, 2015 | 138 | 2015 |
| Tissue specificity of human disease module M Kitsak, A Sharma, J Menche, E Guney, SD Ghiassian, J Loscalzo, ... Scientific reports 6 (1), 1-12, 2016 | 71 | 2016 |
| Network medicine framework for identifying drug repurposing opportunities for COVID-19 DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ... ArXiv, 2020 | 60 | 2020 |
| Endophenotype network models: common core of complex diseases SD Ghiassian, J Menche, DI Chasman, F Giulianini, R Wang, P Ricchiuto, ... Scientific reports 6 (1), 1-13, 2016 | 55 | 2016 |
| Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients T Mellors, JB Withers, A Ameli, A Jones, M Wang, L Zhang, HN Sanchez, ... Network and Systems Medicine 3 (1), 91-104, 2020 | 4 | 2020 |
| Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19 D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ... arXiv e-prints, arXiv: 2004.07229, 2020 | 1 | 2020 |
| Network medicine: a network-based approach to human diseases. SD Ghiassian | 1 | 2015 |
| A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study M Wang, JB Withers, P Ricchiuto, I Voitalov, M McAnally, HN Sanchez, ... Life science alliance 4 (5), 2021 | | 2021 |
| Methods and systems for predicting response to anti-tnf therapies KJ Johnson, SD Ghiassian US Patent App. 16/394,046, 2019 | | 2019 |
| System and Methods for Disease Module Detection S Ghiassian, J Menche, A Sharma, A Barabasi US Patent App. 15/913,826, 2019 | | 2019 |
| PRISM-RA: A Personalized Medicine Test That Accurately Predicts Rheumatoid Arthritis Patients Who Will Not Respond Adequately to Tumor Necrosis Factor Inhibitors K Johnson 2018 ACR/ARHP Annual Meeting, 2018 | | 2018 |
| System and Methods for Disease Module Detection S Ghiassian, J Menche, A Sharma, A Barabasi US Patent App. 15/023,582, 2016 | | 2016 |
| Network topological analysis reveals the functional cohesiveness for the newly discovered links by Yeast 2 Hybrid approach S Ghiassian, S Pevzner, T Rolland, M Tassan, AL Barabasi, M Vidal, ... APS March Meeting Abstracts 2014, L15. 010, 2014 | | 2014 |
| A Network Approach to Rare Disease Modeling S Ghiassian, S Rabello, A Sharma, O Wiest, AL Barabasi APS March Meeting Abstracts 2011, Z14. 008, 2011 | | 2011 |
| PMCID: PMC2323270. I Lemmens, C Fontanillo, R Mosca, A Kamburov, SD Ghiassian, X Yang, ... Biophys Res Commun 361 (4), 928-33, 2007 | | 2007 |
| A network-based method to repurpose marketed therapeutics for antiviral use: A SARS-CoV-2 case study S Ghiassian, M Wang, J Withers, P Ricchiuto, I Voitalov, M McAnally, ... | | |
| Supplementary Information: Tissue Specificity of Human Disease Module M Kitsak, A Sharma, J Menche, E Guney, SD Ghiassian, J Loscalzo, ... | | |
Albert-László BarabásiNortheastern University, Harvard Medical SchoolVerifierad e-postadress på neu.edu
